Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:0060073 |
| Name | lymphatic system cancer |
| Definition | An immune system cancer that is located_in the lymphatic system and is characterized by uncontrolled cellular proliferation of lymphoid tissue. |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Path | disease disease of cellular proliferation cancer organ system cancer immune system cancer lymphatic system cancer |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|---|---|---|---|
| MAP2K1 K57N | Trametinib | lymphatic system cancer | sensitive | detail... |
| BRAF V600E | Cobimetinib | lymphatic system cancer | predicted - sensitive | detail... |
| BRAF N486_T491delinsK | Cobimetinib | lymphatic system cancer | predicted - sensitive | detail... |
| MAP2K1 P124L | Cobimetinib | lymphatic system cancer | predicted - sensitive | detail... |
| MAP2K1 P124Q | Cobimetinib | lymphatic system cancer | predicted - sensitive | detail... |
| MAP2K1 P105_I107del | Cobimetinib | lymphatic system cancer | predicted - sensitive | detail... |
| BRAF N486_P490del | Trametinib | lymphatic system cancer | predicted - sensitive | detail... |
| MAP2K1 K57_G61del | Trametinib | lymphatic system cancer | predicted - sensitive | detail... |
| MAP2K1 L98_K104delinsQ | Trametinib | lymphatic system cancer | predicted - resistant | detail... |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03155620 | Phase II | Tazemetostat Tipifarnib Larotrectinib LY3023414 Vemurafenib Selpercatinib Palbociclib Olaparib Ulixertinib Erdafitinib Selumetinib Ensartinib | Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) | Active, not recruiting | USA | CAN | AUS | 1 |